[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

HUP0001515A2 - Pharmaceutical compositions containing cyclosporin - Google Patents

Pharmaceutical compositions containing cyclosporin

Info

Publication number
HUP0001515A2
HUP0001515A2 HU0001515A HUP0001515A HUP0001515A2 HU P0001515 A2 HUP0001515 A2 HU P0001515A2 HU 0001515 A HU0001515 A HU 0001515A HU P0001515 A HUP0001515 A HU P0001515A HU P0001515 A2 HUP0001515 A2 HU P0001515A2
Authority
HU
Hungary
Prior art keywords
cyclamen
fatty acid
pharmaceutical compositions
compositions containing
powder
Prior art date
Application number
HU0001515A
Other languages
Hungarian (hu)
Inventor
Jong Soo Woo
Original Assignee
Novartis Ag.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag. filed Critical Novartis Ag.
Publication of HUP0001515A2 publication Critical patent/HUP0001515A2/en
Publication of HUP0001515A3 publication Critical patent/HUP0001515A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13Cyclosporins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A találmány tárgya egy ciklőspőrintartalmú kőmpőzíciót tartalmazókészítmény. A készítményt azzal jellemezi, hőgy őlyan kőmpőzícióttartalmaz, amelyben 1) hatóanyagként ciklőspőrin; 2) prőpilén-karbőnát; 3) őlaj-kőmpőnensként a zsírsavak és primer alkőhőlőkészterei, a közepesen hősszú szénláncú zsírsav-trigliceridek és azsírsav-mőnőgliceridek közül választőtt vagy több anyag, és 4) egy 8és 17 közötti HLB-értékű felületaktív anyag van jelen. Aciklőspőrinkészítmények imműnszűppressziós és gyűlladásgátló hatásúgyógyszerként használhatók. ŕThe subject of the invention is a preparation containing a stone emporium containing cyclamen sporin. The preparation is characterized by the fact that it contains a thermal stone composition, in which 1) cyclamen powder is the active ingredient; 2) propylene carbonate; 3) one or more substances selected from among fatty acids and their primary alkaloids, medium-heat carbon chain fatty acid triglycerides and aziri fatty acid mineral glycerides, and 4) a surfactant with an HLB value of between 8 and 17 is present as a kerosene mineral component. Acyclic powder preparations can be used as immunosuppressive and anti-inflammatory medicines. ŕ

HU0001515A 1997-03-14 1998-03-12 Pharmaceutical compositions containing cyclosporin HUP0001515A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1019970008750A KR19980073479A (en) 1997-03-14 1997-03-14 Cyclosporine-containing soft capsules
PCT/EP1998/001432 WO1998041225A1 (en) 1997-03-14 1998-03-12 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
HUP0001515A2 true HUP0001515A2 (en) 2000-09-28
HUP0001515A3 HUP0001515A3 (en) 2000-10-30

Family

ID=19499792

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0001515A HUP0001515A3 (en) 1997-03-14 1998-03-12 Pharmaceutical compositions containing cyclosporin

Country Status (24)

Country Link
EP (1) EP0969857A1 (en)
JP (1) JP3748573B2 (en)
KR (2) KR19980073479A (en)
CN (1) CN1161150C (en)
AR (1) AR012054A1 (en)
AU (1) AU741923B2 (en)
BR (1) BR9808324A (en)
CA (1) CA2283901A1 (en)
CO (1) CO4940404A1 (en)
CZ (1) CZ324399A3 (en)
DE (1) DE19882184T1 (en)
GB (1) GB2337703A (en)
HU (1) HUP0001515A3 (en)
ID (1) ID23531A (en)
IL (1) IL131703A0 (en)
MY (1) MY118614A (en)
NO (1) NO994436L (en)
PE (1) PE59499A1 (en)
PL (1) PL335729A1 (en)
RU (1) RU2185188C2 (en)
SK (1) SK123299A3 (en)
TR (1) TR199902229T2 (en)
WO (1) WO1998041225A1 (en)
ZA (1) ZA982117B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2380674B (en) * 1998-03-06 2003-05-28 Novartis Ag Emulsion preconcentrates containing cyclosporin or a macrolide
US7203158B2 (en) * 2000-12-06 2007-04-10 Matsushita Electric Industrial Co., Ltd. OFDM signal transmission system, portable terminal, and e-commerce system
GB0526419D0 (en) * 2005-12-23 2006-02-08 Cyclacel Ltd Formulation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5603951A (en) * 1994-11-09 1997-02-18 Hanmi Pharm. Ind. Co., Ltd. Cyclosporin-containing soft capsule compositions
KR0167613B1 (en) * 1994-12-28 1999-01-15 한스 루돌프 하우스, 니콜 케르커 Cyclosporin-containing soft capsule compositions
WO1997004810A1 (en) * 1995-07-28 1997-02-13 The Regents Of The University Of California Dax-1 protein, methods for production and use thereof
NZ280689A (en) * 1995-12-15 1997-08-22 Bernard Charles Sherma Sherman Pharmaceutical composition comprising a cyclosporipharmaceutical composition comprising a cyclosporin; a tocol, tocopherol or tocotrienol; and propylen; a tocol, tocopherol or tocotrienol; and propylene carbonate or polyethylene glycol ne carbonate or polyethylene glycol
KR0183449B1 (en) * 1996-06-19 1999-05-01 한스 루돌프 하우스, 니콜 케르커 Cyclosporin-containing soft capsule preparations
KR20040000379A (en) * 1996-06-19 2004-01-03 노파르티스 아게 Cyclosporin-containing soft capsule preparations

Also Published As

Publication number Publication date
GB9921495D0 (en) 1999-11-17
KR20000075940A (en) 2000-12-26
RU2185188C2 (en) 2002-07-20
AR012054A1 (en) 2000-09-27
JP3748573B2 (en) 2006-02-22
CA2283901A1 (en) 1998-09-24
NO994436D0 (en) 1999-09-13
TR199902229T2 (en) 1999-12-21
WO1998041225A1 (en) 1998-09-24
KR19980073479A (en) 1998-11-05
CN1161150C (en) 2004-08-11
DE19882184T1 (en) 2000-02-10
ID23531A (en) 2000-04-27
PL335729A1 (en) 2000-05-08
SK123299A3 (en) 2000-02-14
ZA982117B (en) 1998-09-14
PE59499A1 (en) 1999-07-05
HUP0001515A3 (en) 2000-10-30
CN1250378A (en) 2000-04-12
BR9808324A (en) 2000-05-16
EP0969857A1 (en) 2000-01-12
AU741923B2 (en) 2001-12-13
MY118614A (en) 2004-12-31
AU6729398A (en) 1998-10-12
GB2337703A (en) 1999-12-01
NO994436L (en) 1999-09-13
CZ324399A3 (en) 1999-12-15
JP2000514831A (en) 2000-11-07
IL131703A0 (en) 2001-03-19
CO4940404A1 (en) 2000-07-24

Similar Documents

Publication Publication Date Title
MY125651A (en) Eplerenone compositions
DE69804624D1 (en) SELF-TEMPERATURE FORMULATION CONTAINING LIPOPHILE COMPOUNDS
CA2294031A1 (en) Self-emulsifying formulation for lipophilic compounds
HUP0400566A2 (en) Pharmaceutical preparation comprising an active dispersed on a matrix
HUP0201444A2 (en) Oral pharmaceutical compositions containing long-chain triglycerides and lipophilic surfactants
ATE536173T1 (en) MODIFIED RELEASE FORMULATIONS OF AT LEAST ONE FORM OF TRAMADOL
MY127430A (en) Solid lipid formulations comprising an inhibitor of lipases and a fatty acid ester of polyols
ATE333267T1 (en) MICROEMULSION PRECONCENTRATE, MICROEMULSION AND USE OF A COMPOSITION
JO2386B1 (en) Dispersion formulations containing lipase inhibitors
KR960021018A (en) Pharmaceutical composition
HUP9801052A2 (en) Oral cyclosporin formulations
HUP0001515A2 (en) Pharmaceutical compositions containing cyclosporin
HUP0100303A2 (en) Porous hydroxyapatite particles as carriers for drug substances
EE05231B1 (en) Tramadol Hydrochloride Containing Controlled Release Pharmaceutical Composition and Method for its Preparation
HUP0003330A2 (en) Pharmaceutical compositions containing tizoxanide and nitazoxanide
JPS5668619A (en) Nifedipine-containing solid composition
PT1128820E (en) FRAMACEUTIC MIX UNDERSTANDING A COMBINATION OF PROFEN AND OTHER ACTIVE COMPOUNDS
HUP0104606A2 (en) A pharmaceutical mixture comprising a profen
AU5058400A (en) Pharmaceutical composition containing an extrusion additive
CA2572498A1 (en) Biphasic capsule formulation
DE69838981D1 (en) Component and compositions for the administration of active ingredients
EP0858805A3 (en) Transdermal preparations of oxicams
TH57976B (en) Eplyrenone components
TH37488A (en) Pharmaceutical mixtures
TH26734B (en) The cyclodextrin solid mixture prepared by extrusion on melting.